Literature DB >> 17060133

Protein S-100 and neuropsychological functioning following severe traumatic brain injury.

Sharon E Watt1, E Arthur Shores, Ian J Baguley, Nicholas Dorsch, Michael R Fearnside.   

Abstract

PRIMARY
OBJECTIVE: To examine the relationship between serum concentrations of protein S-100beta and neuropsychological functioning following severe traumatic brain injury.
DESIGN: Matched control group.
METHODS: Blood samples were taken within 12 hours of injury and then daily up to 7 days post-injury (n=23). Within 2 weeks of emerging from post-traumatic amnesia (PTA), participants completed a battery of neuropsychological measures. These results were compared with a matched sample of healthy controls.
RESULTS: Early measurement of S-100 not only reflected overall brain injury severity, but also related to neuropsychological deficits, with higher serum concentrations associated with poorer performance across most cognitive domains. PTA duration, measured by the Westmead PTA Scale, was found to be the strongest predictor of S-100 concentration (R2=0.59, p<0.001).
CONCLUSIONS: These findings show that measurement of serum protein S-100 may further aid in the identification of individuals with severe TBI who are likely to experience cognitive difficulties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060133     DOI: 10.1080/02699050600909698

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  8 in total

1.  Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.

Authors:  Linda Papa; Lawrence M Lewis; Jay L Falk; Zhiqun Zhang; Salvatore Silvestri; Philip Giordano; Gretchen M Brophy; Jason A Demery; Neha K Dixit; Ian Ferguson; Ming Cheng Liu; Jixiang Mo; Linnet Akinyi; Kara Schmid; Stefania Mondello; Claudia S Robertson; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  Ann Emerg Med       Date:  2011-11-08       Impact factor: 5.721

Review 2.  The Effects of Moderate-to-Severe Traumatic Brain Injury on Episodic Memory: a Meta-Analysis.

Authors:  Eli Vakil; Yoram Greenstein; Izhak Weiss; Sarit Shtein
Journal:  Neuropsychol Rev       Date:  2019-08-13       Impact factor: 7.444

3.  Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention.

Authors:  Linda Papa; Lawrence M Lewis; Salvatore Silvestri; Jay L Falk; Philip Giordano; Gretchen M Brophy; Jason A Demery; Ming Cheng Liu; Jixiang Mo; Linnet Akinyi; Stefania Mondello; Kara Schmid; Claudia S Robertson; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  J Trauma Acute Care Surg       Date:  2012-05       Impact factor: 3.313

4.  Prognostic properties of the association between the S-100B protein levels and the mean cerebral blood flow velocity in patients diagnosed with severe traumatic brain injury.

Authors:  Sebastian Dzierzęcki; Mirosław Ząbek; Artur Zaczyński; Ryszard Tomasiuk
Journal:  Biomed Rep       Date:  2022-05-19

5.  Does serum osmolarity change as a result of the reflex neuroprotective mechanism of cerebral osmo-regulation after minor head trauma?

Authors:  Naci Balak; Nilgün Isiksacan; Recai Turkoglu
Journal:  J Korean Neurosurg Soc       Date:  2009-03-31

Review 6.  Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.

Authors:  Eric Peter Thelin; Frederick Adam Zeiler; Ari Ercole; Stefania Mondello; András Büki; Bo-Michael Bellander; Adel Helmy; David K Menon; David W Nelson
Journal:  Front Neurol       Date:  2017-07-03       Impact factor: 4.003

Review 7.  A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury.

Authors:  Eric Peter Thelin; David W Nelson; Bo-Michael Bellander
Journal:  Acta Neurochir (Wien)       Date:  2016-12-12       Impact factor: 2.216

8.  Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.

Authors:  Eric Peter Thelin; Emma Jeppsson; Arvid Frostell; Mikael Svensson; Stefania Mondello; Bo-Michael Bellander; David W Nelson
Journal:  Crit Care       Date:  2016-09-08       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.